The effect of 'MaxEPA' in the treatment of patients with Behçet's disease.
Kürkçüoğlu
N
N
Tandoğdu
R
R
D001528:Behcet Syndrome / Q000188:drug therapy*; D004042:Dietary Fats, Unsaturated / Q000627:therapeutic use; D004281:Docosahexaenoic Acids; D004338:Drug Combinations; D015118:Eicosapentaenoic Acid; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use*; D005260:Female; D005395:Fish Oils / Q000627:therapeutic use*; D006801:Humans; D008297:Male
D004042:Dietary Fats, Unsaturated; D004338:Drug Combinations; D015525:Fatty Acids, Omega-3; D005395:Fish Oils; C045153:Maxepa; D004281:Docosahexaenoic Acids; D015118:Eicosapentaenoic Acid